
Gene therapy products present a unique set of challenges for the control of host cell protein impurities.
Art Cansizoglu, PhD, is senior scientist with Charles River.
Gene therapy products present a unique set of challenges for the control of host cell protein impurities.
Published: July 15th 2021 | Updated: